摘要
目的 :探讨癌基因c myc、bcl 2蛋白产物在上颌窦癌中的表达情况及其临床意义。方法 :采用免疫组织化学方法 ,对 4 6例上颌窦癌及 5 6例正常鼻粘膜组织中癌基因c myc、bcl 2蛋白产物进行检测。 结果 :正常鼻粘膜鳞状上皮细胞中癌基因c myc、bcl 2蛋白阳性率为 0 ;上颌窦癌细胞中 ,癌基因c myc、bcl 2蛋白阳性率分别为 73.91% (34/46 )、6 0 .87% (2 8/46 )。复发组c myc蛋白的阳性率 (91.6 7% )显著高于未复发组 (6 7.6 5 % ) ,P<0 .0 1;复发组bcl 2蛋白的阳性率 (5 0 .0 % )明显低于未复发组 (6 4 .71% ) ,P <0 .0 5。c myc蛋白阳性率随临床分期的增加而升高 ,其中Ⅳ期阳性率 (88.89% )明显高于Ⅱ期 (6 3.6 4 % ) ,P <0 .0 5 ;bcl 2蛋白阳性率随临床分期的增加而下降 ,Ⅳ期阳性率 (5 5 .5 6 % )明显低于Ⅱ期 (72 .73% ) ,P <0 .0 5。bcl 2蛋白的阳性率随原发癌病理分级的降低而下降 ,低分化组 (5 6 .2 5 % )明显低于高分化组 (71.4 3% )和中分化组 (6 2 .5 0 % ) ,P <0 .0 1和 0 .0 5 ;中分化组 (6 2 .5 0 % )亦明显低于高分化组 (71.4 3% ) ,P <0 .0 5 ;p6 2 c myc的阳性率与原发癌病理分级无明显关系。结论 :c myc、bcl 2基因参与了上颌窦的癌变及发展过程 。
Objective:To determine the oncogene c myc,bcl 2′ product expression in the maxillary sinus cancer and to investigate its clinical significance.Method:In 46 maxillary sinus cancer and 56 normal nasal mucous membrane,immunochemical method was adopted to determine oncogene c myc and bcl 2′ product.Result:In the normal nasal mucous membrane,the positive rates of oncogene c myc and bcl 2′ product were 0;in the maxillary sinus cancer,the positive rates of c myc and bcl 2′ product were 73.91 (34/46), 60.87 (28/46)respectively.The positive rate of c myc′ product in the relapse group( 91.67 %,11/12) was significantly higher than that in the non relapse group( 67.65 %,23/34),P< 0.01 ;the positive rate of bcl 2′ product in the relapse group(50%,6/12) was significantly lower than that in the non relapse group( 64.71 %,22/34),P< 0.05 ;the positive rate of c myc′ product in the stage Ⅳ( 88.89 %,8/9) was significantly higher than that in the stage Ⅱ ( 63.64 %,7/11),P< 0.05 ;the positive rate of bcl 2′ product in the stage Ⅱ( 72.73 %,8/11) was significantly higher than that in the stage Ⅳ( 55.56 %,5/9),P< 0.05 ;the positive rate of bcl 2′ product was in the negative correlation to the pathological grade of primary carcinoma.Conclusion:The oncogene c myc and bcl 2 take part in the genesis and advancing course of maxillary sinus cancer.Their products were the important oncogology indexes,which might be useful to determine illness condition and predict relapse.
出处
《临床耳鼻咽喉科杂志》
CSCD
北大核心
2001年第11期496-498,共3页
Journal of Clinical Otorhinolaryngology